期刊文献+

ERG基因在胃癌组织中的表达及其临床意义 被引量:1

ERG gene expression in gastric cancer and its clinical significance
下载PDF
导出
摘要 目的:探讨ERG基因与胃癌易感性的关系及其临床意义。方法:采用实时荧光定量PCR技术分别检测120例胃癌组织和120正常胃黏膜组织中ERG基因的表达量。结果:ERG基因在胃癌组织中的表达较正常胃黏膜组织明显增高(P<0.001);ERG基因的表达在T4、T3、T2、T1胃癌组织中表达呈下降趋势(P=0.006),在N3、N2、N1、N0胃癌中表达亦呈下降趋势(P=0.017)。结论:ERG基因表达的上调增加胃癌的易感性,并且与胃癌的局部浸润范围和淋巴结转移有关。 Objective To explore the association between ERG gene and gastric cancer susceptibility, as well as its clinical significance. Methods qRT-PCR was used to detect ERG gene expression in gastric cancer tissues from 120 patients and in 120 samples of normal gastric nmcosa tissues. Results The expression of ERG gene was significantly higher in gastric cancer tissues than in normal gastric mucosa tissues (P 〈 0.001 ) ; the expressions of ERG gene at stages T4, T3, T2, and T1 gastric cancer tissues showed a downward trend (P = 0.006), so did they at stages N3, N2, N1, and NO (P = 0.017). Conclusion ERG gene upregulation increases the susceptibility of gastric cancer, and is correlated with local invasion extent and lymph node metastasis.
出处 《实用医学杂志》 CAS 北大核心 2013年第1期23-25,共3页 The Journal of Practical Medicine
基金 江西省教育厅2011年度科技项目(编号:GJJ11352)
关键词 胃肿瘤 ERG基因 实时荧光定量PCR Stomach neoplasms ERG gene qRT-PCR
  • 相关文献

参考文献6

二级参考文献68

  • 1Xiu-Sheng He Qi Su Zhu-Chu Chen Xiu-Tao He Zhi-Feng Long Hui Ling Liang-Run Zhang Oncology Institute,Nanhua University,Hengyang 421001,Hunan Province,ChinaOncology Institute,Center South University,Changsha 410078,Hunan Province,China Department of Gastroenterology,First People’s Hospital of Changde City,Changde 415003,Hunan Province,China.Expression,deleton and mnutation of ρ16 gene in human gastric cancer[J].World Journal of Gastroenterology,2001,7(4):515-521. 被引量:40
  • 2Tomlins S A, Rhodes D R, Perner S, et al. Recur- rent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer[J]. Science, 2005, 310:644 -648.
  • 3Petrovics G, Liu A J, Shaheduzzaman S, et al. Fre- quent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome [J]. Oncogene, 2005, 24 (23): 3847-3852.
  • 4Marcucci G, Baldus C D, Ruppert A S, et al. Over- expression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: A cancer and leukemia group B study[J]. J Clin Oncol, 2005, 23 (36): 9234-9242.
  • 5Klezovitch O, Risk M, Coleman 1, et at. A causal role for ERG in neoplastic transformation of prostate epithelium[J]. Proc Natl Acad Sci U S A, 2008, 105 (6) : 2105-2110.
  • 6Turner D P, Watson D K. ETS transcription factors: oncogenes and tumor suppressor genes as therapeutictargets for prostate cancer[J]. Expert Rev Antieancer Ther, 2008, 8(1): 33-42.
  • 7Demichelis F, Fall K, Perner S, et al. TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort[J]. Oncogene, 2007, 26: 4596-4599.
  • 8Vaarala M H, Porvari K S, Kellokumpu S, et al. Expression of transmembrane serine protease TM PRSS2 in mouse and human tissues [J].J Pathol 2001, 193(1):134-140.
  • 9Vaarala M H, Porvari K, Kyllonen A, et al. The TMPRSS2 gene encoding transmembrane serine pro- tease is overexpressed in a majority of prostate cancer patients: detection of mutated TMPRSS2 form in a case of aggressive disease[J]. Int J Cancer, 2001, 94 (5) : 705-710.
  • 10Boormans J L, Verhagen P C M S, Ziel-Van Der Made A C J, et al. Does expression of TMRSS2: ERG fusion gene in lymph node metastases predict response to endocrine therapy in hormone-na? ve pros- tate cancer[J]. Eur Urol, 2008,7(3) Suppl: 254.

共引文献13

同被引文献13

  • 1GUTIERREZ HARTMANN A, DUVAL D, LBRADFORD A P. ETS transcription factors in endocrine systems [ J 1- Trends Endo- crinot Metab, 2007, 18(4) : 150 - 158.
  • 2CARVER B S, TRAN J, GOPALAN A, et al. Aberrant ERG ex- pression cooperates with loss of PTEN to promote cancer progres- sion in the prostate[J]. Nat Genet, 2009, 41 (5) : 619 -624.
  • 3COSKUN E, VON DER HEIDE E K, SCHLEE C, et al. The role of microRNA - 196a and microRNA - 196b as ERG regulators in acute myeloid leukemia and acute T- lymphoblastic leukemia[ J]. Leuk Res, .?.010, 35(2) : 208 -213.
  • 4ZHENG L, PU J, QI T, et al. miRNA - 145 targets v - ets etyth- roblastosis virus E26 oncogene homolog 1 to suppress the invasion, metastasis, and angiogenesis of gastric cancer cells[ Jl. Mol Can- cer Res, 2012, 11 (2) : 182 - 193.
  • 5AMBROS V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing[J]. Cell, 2003, 113(6) : 673 - 676.
  • 6SETH AWATSON D K. ETS transcription factors and their emergingroles in human cancer[J~. Eur J Cancer, 2005, 41 (16) : 2462 - 2478.
  • 7DEJANA E, TADDEI ARANDI A M. Foxs and Ets in the tran- scriptional regulation of endothelial cell differentiation and angio- genesis [ J ]. Bioehim Biophys Aeta, 2007, 1775 (2) : 298 - 312.
  • 8BARWICK B G, ABRAMOVITZ M, KODANI M, et al. Prostate cancer genes assoeiated with TMPRSS2 - ERG gene fusion and prognostic of biochemical recurrence in muhipte cohorts[ J]. Br J Cancer, 2010, 102(3): 570-576.
  • 9CAI J, KANDAGATLA P, SINGAREDDY R, et al. Androgens induce functional CXCR4 through ERG factor expression in TM- PRSS2 - ERG fusion - positive prostate cancer cells [ J ]. Transl Oneol, 2010, 3(3) : 195 -203.
  • 10MARCUCCI G, BALDUS C D, RUPPERT A S, et al. Overex- pression of the ETS -related gene, ERG, predicts a worse out- come in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study[ J~. J Clin Oncol, 2005, 23 (36) : 9234 - 9242.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部